tiprankstipranks
Advertisement
Advertisement

Hangzhou Tigermed Releases 2025 Q1 Report

Story Highlights
Hangzhou Tigermed Releases 2025 Q1 Report

Elevate Your Investing Strategy:

Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ) has issued an update.

Hangzhou Tigermed Consulting Co., Ltd. released its first quarterly report for 2025, highlighting that the financial statements were prepared according to the China Accounting Standards for Business Enterprises and remain unaudited. The report serves as a disclosure in compliance with Hong Kong’s listing rules, providing stakeholders with essential financial information.

More about Hangzhou Tigermed Consulting Co., Ltd. Class H

Hangzhou Tigermed Consulting Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, primarily operating in the consulting industry. The company, along with its subsidiaries, focuses on providing comprehensive consulting services.

YTD Price Performance: -18.58%

Average Trading Volume: 121

Technical Sentiment Signal: Buy

Current Market Cap: €3.97B

See more data about 3347 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1